by Cryostem | Nov 16, 2023
On this occasion, two posters will be presented on strategies for valorising the collection (poster 36) and the ancillary study of the FIBRAPLO clinical protocol (poster 40). All the posters selected for this edition are available for viewing and downloading on the... 
by Cryostem | Mar 18, 2022
Several CRYOSTEM players are participating in the 48th EBMT annual meeting. Here is a selection of posters and presentations that will be held as part of the scientific program: Dr. Eolia Brissot, member of the CRYOSTEM Scientific Committee: Monday, March 21, 09:00... 
by Cryostem | Oct 27, 2021
Rheos Medicines Forms Research Collaboration with CRYOSTEM to Evaluate MALT1 Targeted Therapeutics for Graft-versus-Host-Disease CAMBRIDGE, Mass., and MARSEILLE, France, October 27, 2021 – Rheos Medicines, a biopharmaceutical company bringing molecular targeting and... 
by Cryostem | Sep 27, 2021
Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy. Marie Tourret, Nana Talvard-Balland, Marion Lambert, Ghada Ben Youssef, Mathieu F. Chevalier, Armelle Bohineust, Thomas Yvorra, Florence Morin,... 
